Opportunity Overview
However, currently, AI models in medicine are still only measured by accuracy, leaving their impact on inequalities untested. Current AI audit tools are not fit for purpose as they do not detect and quantity bias based on actual health needs. Largely absent are effective tools devised particularly for healthcare for evaluating and mitigating AI induced inequalities. This project aims to develop a set of tools for optimising health datasets and supporting AI development in ensuring equity. Central to the solution is a novel measurement tool for quantifying health inequalities: deterioration-allocation area under curve. This...
This is one of 44 active United Kingdom Pharmaceuticals opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | MRC |
|---|---|
| Country | United Kingdom |
| Category | Pharmaceuticals |
| Published | September 30, 2023 |
| Procurement stage | Active solicitation |
| Response due | January 31, 2027 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | August 12, 2026 |
Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.
Related Opportunities in United Kingdom
See every United Kingdom Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United Kingdom Pharmaceuticals intelligence report in your inbox
A personalized report on United Kingdom Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.